| Heart disease and stroke statistics 2005 update American Heart Association http://www. americanheart. org/statistics/, 2005 | 8580* | 2005 |
| Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke JL Saver, GC Fonarow, EE Smith, MJ Reeves, MV Grau-Sepulveda, ... Jama 309 (23), 2480-2488, 2013 | 1009 | 2013 |
| Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times … GC Fonarow, EE Smith, JL Saver, MJ Reeves, DL Bhatt, ... Circulation 123 (7), 750-758, 2011 | 760 | 2011 |
| Consensus summary statement of the international multidisciplinary consensus conference on multimodality monitoring in neurocritical care: a statement for healthcare … P Le Roux, DK Menon, G Citerio, P Vespa, MK Bader, GM Brophy, ... Neurocritical care 21, 1-26, 2014 | 567 | 2014 |
| Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke GC Fonarow, MJ Reeves, EE Smith, JL Saver, X Zhao, DW Olson, ... Circulation: Cardiovascular Quality and Outcomes 3 (3), 291-302, 2010 | 386 | 2010 |
| Global incidence of neurological manifestations among patients hospitalized with COVID-19—a report for the GCS-NeuroCOVID consortium and the ENERGY consortium SHY Chou, E Beghi, R Helbok, E Moro, J Sampson, V Altamirano, ... JAMA network open 4 (5), e2112131-e2112131, 2021 | 360 | 2021 |
| Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With the Guidelines–Stroke Program EE Smith, N Shobha, D Dai, DWM Olson, MJ Reeves, JL Saver, ... Circulation 122 (15), 1496-1504, 2010 | 309 | 2010 |
| Secondary preventive medication persistence and adherence 1 year after stroke CD Bushnell, DM Olson, X Zhao, W Pan, LO Zimmer, LB Goldstein, ... Neurology 77 (12), 1182-1190, 2011 | 307 | 2011 |
| The “golden hour” and acute brain ischemia: presenting features and lytic therapy in> 30 000 patients arriving within 60 minutes of stroke onset JL Saver, EE Smith, GC Fonarow, MJ Reeves, X Zhao, DWM Olson, ... Stroke 41 (7), 1431-1439, 2010 | 294 | 2010 |
| Race/ethnicity, quality of care, and outcomes in ischemic stroke LH Schwamm, MJ Reeves, W Pan, EE Smith, MR Frankel, DW Olson, ... Circulation 121 (13), 1492-1501, 2010 | 279 | 2010 |
| Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke CB Lin, ED Peterson, EE Smith, JL Saver, L Liang, Y Xian, DWM Olson, ... Circulation: Cardiovascular quality and outcomes 5 (4), 514-522, 2012 | 277 | 2012 |
| Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke GC Fonarow, MJ Reeves, X Zhao, DWM Olson, EE Smith, JL Saver, ... Circulation 121 (7), 879-891, 2010 | 269* | 2010 |
| Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from Get With the Guidelines–Stroke EE Smith, GC Fonarow, MJ Reeves, M Cox, DWM Olson, AF Hernandez, ... Stroke 42 (11), 3110-3115, 2011 | 262 | 2011 |
| Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator BK Menon, JL Saver, S Prabhakaran, M Reeves, L Liang, DWM Olson, ... Stroke 43 (9), 2293-2299, 2012 | 261 | 2012 |
| Relationship of national institutes of health stroke scale to 30day mortality in medicare beneficiaries with acute ischemic stroke GC Fonarow, JL Saver, EE Smith, JP Broderick, DO Kleindorfer, RL Sacco, ... Journal of the American Heart Association 1 (1), e000034, 2012 | 242 | 2012 |
| Sex differences in quality of life after ischemic stroke CD Bushnell, MJ Reeves, X Zhao, W Pan, J Prvu-Bettger, L Zimmer, ... Neurology 82 (11), 922-931, 2014 | 228 | 2014 |
| Association of preceding antithrombotic treatment with acute ischemic stroke severity and in-hospital outcomes among patients with atrial fibrillation Y Xian, EC O’Brien, LI Liang, H Xu, LH Schwamm, GC Fonarow, DL Bhatt, ... Jama 317 (10), 1057-1067, 2017 | 222 | 2017 |
| Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator Y Xian, L Liang, EE Smith, LH Schwamm, MJ Reeves, DWM Olson, ... Jama 307 (24), 2600-2608, 2012 | 214 | 2012 |
| Interrater reliability of pupillary assessments DWM Olson, S Stutzman, C Saju, M Wilson, W Zhao, V Aiyagari Neurocritical care 24, 251-257, 2016 | 205 | 2016 |
| Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity GC Fonarow, W Pan, JL Saver, EE Smith, MJ Reeves, JP Broderick, ... Jama 308 (3), 257-264, 2012 | 204 | 2012 |
